Kentaro Kogure Selected Research

AT1002

6/2021	Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-κB decoy oligodeoxynucleotide.
1/2017	Development of flexible nanocarriers for siRNA delivery into tumor tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Kogure Research Topics

Disease

26	Neoplasms (Cancer) 05/2022 - 01/2002
6	Melanoma (Melanoma, Malignant) 01/2022 - 03/2003
6	Insulin Resistance 05/2014 - 01/2011
4	Fatty Liver 01/2022 - 01/2011
4	Inflammation (Inflammations) 10/2020 - 04/2009
3	Brain Ischemia (Cerebral Ischemia) 02/2022 - 01/2020
3	Reperfusion Injury 02/2022 - 01/2012
3	Leukemia 01/2021 - 05/2019
2	Ischemic Stroke 02/2022 - 01/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2021 - 10/2020
2	Hyperplasia 06/2021 - 10/2020
2	Dry Eye Syndromes (Dry Eye Syndrome) 05/2020 - 01/2019
2	Stomach Ulcer (Gastric Ulcer) 01/2018 - 09/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2014 - 11/2013
2	Iron Overload 01/2013 - 01/2013
2	Non-alcoholic Fatty Liver Disease 01/2013 - 10/2012
2	Carcinoma (Carcinomatosis) 03/2009 - 01/2002
1	Colonic Neoplasms (Colon Cancer) 05/2022
1	Phobic Disorders (Phobia) 02/2022
1	Arthritis (Polyarthritis) 02/2022
1	Edema (Dropsy) 02/2022
1	Rheumatoid Arthritis 02/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Peptic Ulcer (Peptic Ulcers) 09/2016

Drug/Important Bio-Agent (IBA)

13	Liposomes (Liposome)IBA 02/2022 - 02/2007
7	Pharmaceutical PreparationsIBA 02/2022 - 02/2007
6	LipidsIBA 01/2022 - 11/2003
6	Peptides (Polypeptides)IBA 06/2021 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
5	Succinic Acid (Succinate)IBA 05/2022 - 05/2004
4	Messenger RNA (mRNA)IBA 06/2021 - 12/2014
3	Biological ProductsIBA 02/2022 - 10/2020
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2022 - 05/2019
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 05/2015
3	Therapeutic UsesIBA 01/2017 - 08/2013
3	FructoseIBA 01/2013 - 10/2012
2	Tocopherols (Tocopherol)IBA 02/2022 - 01/2020
2	Neuroprotective AgentsIBA 02/2022 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	AntibodiesIBA 09/2021 - 10/2020
2	AT1002IBA 06/2021 - 01/2017
2	OligodeoxyribonucleotidesIBA 06/2021 - 03/2011
2	EstersIBA 01/2021 - 05/2004
2	Drug CarriersIBA 01/2021 - 01/2017
2	astaxanthine (astaxanthin)IBA 05/2020 - 01/2019
2	AntioxidantsIBA 01/2019 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 12/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 09/2016
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2018 - 09/2016
2	ResistinIBA 05/2014 - 11/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 10/2012
2	Insulin (Novolin)FDA Link 01/2013 - 10/2012
2	tamibaroteneIBA 01/2013 - 10/2012
2	IronIBA 01/2013 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2010 - 10/2007
2	Tuberculin (PPD)IBA 01/2010 - 10/2007
2	lysophosphatidic acidIBA 10/2002 - 01/2002
2	alkylglycerophosphoethanolamine phosphodiesteraseIBA 10/2002 - 01/2002
1	Interleukin-10 (Interleukin 10)IBA 05/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022
1	alpha-tocopherol phosphateIBA 02/2022
1	laminaranIBA 02/2022
1	SolutionsIBA 02/2022
1	Lipid NanoparticlesIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 09/2021
1	CytokinesIBA 06/2021
1	Nucleic AcidsIBA 06/2021
1	hydroxide ionIBA 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	Imiquimod (Aldara)FDA LinkGeneric 10/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	Etanercept (Enbrel)FDA Link 10/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 03/2020
1	Angiopoietin-2IBA 01/2020
1	peony root extractIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	PowdersIBA 01/2018
1	Phosphatidic Acids (Phosphatidic Acid)IBA 09/2016
1	Protective AgentsIBA 09/2016
1	NanogelsIBA 04/2015
1	AntigensIBA 04/2015
1	Plasminogen Activator Inhibitor 1IBA 05/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	Nanoparticle Drug Delivery SystemIBA 01/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2014
1	AlginatesIBA 12/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 02/2007
3	Intravenous Administration 10/2007 - 03/2003
2	Subcutaneous Injections 02/2022 - 10/2020
2	Immunotherapy 03/2011 - 03/2009
1	Intraperitoneal Injections 02/2022
1	Intravenous Injections 01/2022
1	Drug Therapy (Chemotherapy) 01/2014